These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21616455)

  • 21. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
    Mueller JE; Borrow R; Gessner BD
    Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reasons for the 2003-2004 meningitis C vaccination campaign in Castilla-La Mancha].
    Marco Hernández M
    An Pediatr (Barc); 2005 Apr; 62(4):381-2; discussion 383. PubMed ID: 15826570
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
    Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?
    Roberts L
    Science; 2010 Dec; 330(6010):1466-7. PubMed ID: 21148362
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.
    Cardoso CW; Pinto LL; Reis MG; Flannery B; Reis JN
    Vaccine; 2012 Aug; 30(37):5541-6. PubMed ID: 22749604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious disease. Hitting early, epidemic meningitis ravages Nigeria and Niger.
    Roberts L
    Science; 2009 Apr; 324(5923):20-1. PubMed ID: 19342555
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The impact of mass vaccination on meningococcal disease in the 1970s epidemic in Brazil].
    Barata RB
    Cad Saude Publica; 2004; 20(6):1762-3; author reply 1764. PubMed ID: 15608883
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mass vaccination campaign against serogroup C meningococcal disease, municipality of Itapeva, Sao Paulo].
    Centro de Vigilância Epidemiológica Prof. Alexandre Vranjac, Secretaria de Estado da Saúde de São Paulo
    Rev Saude Publica; 2005 Feb; 39(1):139-40. PubMed ID: 15654472
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the vaccination campaign in Cantabria 2 years of epidemiological evolution].
    González de Aledo A; García Merino J
    Rev Esp Salud Publica; 2000; 74(4):405-11. PubMed ID: 11031850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious disease. Shortage of meningitis vaccine forces triage in Burkina Faso.
    Vogel G
    Science; 2003 Mar; 299(5612):1499-501. PubMed ID: 12624241
    [No Abstract]   [Full Text] [Related]  

  • 33. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
    Chippaux JP; Diallo A; Marra A; Etard JF
    Vaccine; 2007 Feb; 25(10):1712-8. PubMed ID: 17240492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 36. Update on meningococcal vaccine.
    Peter G
    Pediatr Infect Dis J; 2001 Mar; 20(3):311-2. PubMed ID: 11303836
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparedness for outbreaks of meningococcal meningitis due to Neisseria meningitidis serogroup C in Africa: recommendations from a WHO expert consultation.
    Wkly Epidemiol Rec; 2015 Nov; 90(47):633-6. PubMed ID: 26591025
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meningococcal meningitis.
    Aguado T; Bertherat E; Djingarey M; Kandolo D; Kieny MP; Kondé K; LaForce FM; Nelson CB; Perea W; Préziosi MP
    Nat Rev Microbiol; 2005 Jan; 3(1):10-1. PubMed ID: 15635779
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology of meningococcal meningitis in Angola, 1994-2000.
    Gaspar M; Leite F; Brumana L; Félix B; Stella AA
    Epidemiol Infect; 2001 Dec; 127(3):421-4. PubMed ID: 11811874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.